Antisense Therapeutics Limited (AU:PER) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Percheron Therapeutics Limited has announced a proposed issuance of 135,231,746 ordinary fully paid securities, aimed at boosting its capital. This strategic move is set to take place on October 24, 2024, potentially increasing the company’s market presence and attracting investors. Such placements are often seen as opportunities for growth and expansion within the financial markets.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
